22 related articles for article (PubMed ID: 6547127)
1. Actinomycetes from the Red Sea Sponge
Shamikh YI; El Shamy AA; Gaber Y; Abdelmohsen UR; Madkour HA; Horn H; Hassan HM; Elmaidomy AH; Alkhalifah DHM; Hozzein WN
Microorganisms; 2020 May; 8(5):. PubMed ID: 32456212
[TBL] [Abstract][Full Text] [Related]
2. From Anthramycin to Pyrrolobenzodiazepine (PBD)-Containing Antibody-Drug Conjugates (ADCs).
Mantaj J; Jackson PJ; Rahman KM; Thurston DE
Angew Chem Int Ed Engl; 2017 Jan; 56(2):462-488. PubMed ID: 27862776
[TBL] [Abstract][Full Text] [Related]
3. The antiproliferative function of violacein-like purple violet pigment (PVP) from an Antarctic Janthinobacterium sp. Ant5-2 in UV-induced 2237 fibrosarcoma.
Mojib N; Nasti TH; Andersen DT; Attigada VR; Hoover RB; Yusuf N; Bej AK
Int J Dermatol; 2011 Oct; 50(10):1223-33. PubMed ID: 21790550
[TBL] [Abstract][Full Text] [Related]
4. Biosynthesis, synthesis, and biological activities of pyrrolobenzodiazepines.
Gerratana B
Med Res Rev; 2012 Mar; 32(2):254-93. PubMed ID: 20544978
[TBL] [Abstract][Full Text] [Related]
5. Prothracarcin, a novel antitumor antibiotic.
Shimizu K; Kawamoto I; Tomita F; Morimoto M; Fujimoto K
J Antibiot (Tokyo); 1982 Aug; 35(8):972-8. PubMed ID: 7142014
[TBL] [Abstract][Full Text] [Related]
6. BMY-28438 (3,7-dihydroxytropolone), a new antitumor antibiotic active against B16 melanoma. I. Production, isolation, structure and biological activity.
Sugawara K; Ohbayashi M; Shimizu K; Hatori M; Kamei H; Konishi M; Oki T; Kawaguchi H
J Antibiot (Tokyo); 1988 Jul; 41(7):862-8. PubMed ID: 3417559
[TBL] [Abstract][Full Text] [Related]
7. Porothramycin, a new antibiotic of the anthramycin group: production, isolation, structure and biological activity.
Tsunakawa M; Kamei H; Konishi M; Miyaki T; Oki T; Kawaguchi H
J Antibiot (Tokyo); 1988 Oct; 41(10):1366-73. PubMed ID: 3192492
[TBL] [Abstract][Full Text] [Related]
8. New antitumor antibiotic, FR-900462. II. Production, isolation, characterization and biological activity.
Iwami M; Nakayama O; Okuhara M; Terano H; Kohsaka M
J Antibiot (Tokyo); 1989 May; 42(5):686-90. PubMed ID: 2722682
[TBL] [Abstract][Full Text] [Related]
9. A new antitumor substance, BE-18591, produced by a streptomycete. I. Fermentation, isolation, physico-chemical and biological properties.
Kojiri K; Nakajima S; Suzuki H; Okura A; Suda H
J Antibiot (Tokyo); 1993 Dec; 46(12):1799-803. PubMed ID: 8294236
[TBL] [Abstract][Full Text] [Related]
10. Chicamycin, a new antitumor antibiotic. I. Production, isolation and properties.
Konishi M; Hatori M; Tomita K; Sugawara M; Ikeda C; Nishiyama Y; Imanishi H; Miyaki T; Kawaguchi H
J Antibiot (Tokyo); 1984 Mar; 37(3):191-9. PubMed ID: 6547127
[TBL] [Abstract][Full Text] [Related]
11. Pyrrolo(1,4)benzodiazepine antitumor antibiotics. Comparative aspects of anthramycin, tomaymycin and sibiromycin.
Hurley LH
J Antibiot (Tokyo); 1977 May; 30(5):349-70. PubMed ID: 328469
[No Abstract] [Full Text] [Related]
12. Antitumor antibiotic bioactivation, biotransformation and derivatization by microbial systems.
Rosazza JP
Recent Results Cancer Res; 1978; 63():58-68. PubMed ID: 81506
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
